FindTrial
Sign In

Real-world data analysis of bevacizumab in patients with non-squamous non-small cell lung cancer Study Protocol

Real-world data analysis of bevacizumab in patients with non-squamous non-small cell lung cancer Study Protocol

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016652
Enrollment
Unknown
Registered
2018-06-14
Start date
2018-07-01
Completion date
Unknown
Last updated
2018-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

Case series:NA

Sponsors

Shanghai Chest Hospital, Shanghai Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed and treated after July 2015; 2. histology/cytology confirmed NS-NSCLC; 3. Patients with phase IIIb or IV NS-NSCLC according to TNM staging (7th Edition AJCC); 4. Patients who had been treated with bevacizumab; All eligible patients should be included in order to avoid bias.

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

MeasureTime frame
PFS;ORR;DOR;OS;—

Countries

China

Contacts

Public ContactLu Shun

Shanghai Chest Hospital, Shanghai Jiaotong University

56485747@qq.com+86 13601813062

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026